文献速递外周动脉疾病

早发外周动脉疾病患者行血管内介入治疗后结局更差

Premature peripheral arterial disease is associated with worse outcomes after endovascular peripheral vascular intervention.
PubMed 文献 · J Vasc Surg · 2026-08-04

基于VQI与Medicare联动数据,2017至2018年因动脉闭塞性疾病行PVI的患者中,早发PAD(<50岁)占2.3%。早发PAD患者合并症负担更重、病情更晚期,1年大截肢累积发生率显著更高,但30天、90天及1年全因死亡率与非早发PAD相当。

要点

  • 早发PAD患者行PVI时常表现为慢性肢体威胁性缺血和既往截肢史。
  • 早发PAD患者1年大截肢风险显著高于非早发PAD患者。
  • 早发PAD与非早发PAD患者30天、90天及1年全因死亡率无显著差异。

核心结论

  • 早发PAD患者行PVI代表高风险人群,合并症负担更重、就诊时病情更晚期,1年大截肢率显著更高,但死亡率与非早发PAD相当。

研究设计与样本

  • 共识别15,050例患者,其中非早发PAD 14,699例(97.7%),早发PAD 351例(2.3%)。

主要发现

  • 早发PAD组女性比例更高(49.0% vs 41.2%;P = .003),少数族裔成员比例更高,合并症负担更重。
  • 早发PAD组更常表现为慢性肢体威胁性缺血(79.8% vs 60.3%;P < .001)及既往截肢,包括小截肢(21.4% vs 8.4%;P < .001)和大截肢(19.1% vs 8.7%;P < .001)。
  • 早发PAD组30天(4.6% vs 1.9%;P = .006)、90天(13.7% vs 5.2%;P < .001)和1年(21.9% vs 8.9%;P < .001)大截肢累积发生率显著更高,平均至截肢时间更短(14.6 [10.5] vs 17.3 [10.3]个月;P < .001)。
  • 两组30天、90天及1年全因死亡率无显著差异,平均至死亡时间相似(18.2 vs 18.6个月;P = .52)。
  • 多变量分析中,早发PAD与30天(aHR,0.93;95%CI,0.49-1.75;P = .82)、90天(aHR,0.94;95%CI,0.63-1.40;P = .76)或1年(aHR,0.83;95%CI,0.64-1.07;P = .15)死亡率无关,但仍独立关联90天(aHR,1.62;95%CI,1.20-2.19;P < .001)和1年(aHR,1.57;95%CI,1.24-1.99;P < .0001)大截肢。

关键数值与推荐

  • 早发PAD定义为发病年龄小于50岁。
  • 早发PAD组平均年龄与非早发PAD组相差28.3(4.6)岁。

临床怎么用

  • 对早发PAD患者行PVI时应认识到其高截肢风险,需关注优化药物治疗和靶向干预策略以减少肢体丢失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Premature peripheral arterial disease (PAD), defined as onset before the age of 50 years, is increasing in prevalence. The clinical characteristics, treatment patterns, and mid- and late-term outcomes of patients with premature PAD undergoing endovascular peripheral vascular intervention (PVI) are not well-defined. METHODS: The linked Vascular Quality Initiative and Medicare dataset was used to examine those who underwent PVI for arterial occlusive disease from January 2017 to December 2018. The exclusion criteria were acute limb ischemia and concomitant open revascularization. Patient demographics, operative characteristics, and outcomes were analyzed by group: premature versus nonpremature PAD. The primary outcomes of interest included risk of major amputation and 30-day, 90-day, and 1-year mortality. Time-to-event analyses were employed to calculate the cumulative incidence and derive the risk between the groups for the primary outcomes. RESULTS: A total of 15,050 patients were identified: 14,699 with nonpremature PAD (97.7%) and 351 with premature (2.3%). The premature PAD group had a higher proportion of women (49.0% vs 41.2%; P = .003), higher proportion of minoritized group members, and higher comorbidity burden. The premature PAD group commonly presented with chronic limb-threatening ischemia (79.8% vs 60.3%; P < .001) and prior amputation, both minor (21.4% vs 8.4%; P < .001) and major (19.1% vs 8.7%; P < .001). Patients with premature PAD had a significantly higher cumulative incidence of major amputation at 30 days (4.6% vs 1.9%; P = .006), 90 days (13.7% vs 5.2%; P < .001), and 1 year (21.9% vs 8.9%; P < .001), with a significantly shorter mean time-to-amputation than that of their nonpremature PAD counterparts (14.6 [10.5] vs 17.3 [10.3] months; P < .001). Despite the significant difference in the mean age between the groups (28.3 [4.6] years), no significant difference was noted in 30-day, 90-day, or 1-year all-cause mortality, with a similar mean time-to-death, between the premature and nonpremature PAD groups (18.2 vs 18.6 months; P = .52). In multivariable analysis, premature PAD was not associated with mortality at 30 days (adjusted hazard ratio [aHR], 0.93; 95% confidence interval [CI], 0.49-1.75; P = .82), 90 days (aHR, 0.94; 95% CI, 0.63-1.40; P = .76), or 1 year (aHR, 0.83; 95% CI, 0.64-1.07; P = .15). However, premature PAD remained independently associated with 90-day (aHR, 1.62; 95% CI, 1.20-2.19; P < .001) and 1-year major amputation (aHR, 1.57; 95% CI, 1.24-1.99; P < .0001). CONCLUSIONS: Patients with premature PAD undergoing PVI represent a high-risk population characterized by higher comorbidity burden, advanced disease at presentation, significantly higher 1-year major amputation rates, and comparable mortality to patients with nonpremature PAD despite an almost 30-year difference in the mean age between the groups. Further work should focus on identifying the barriers to optimal medical therapy and developing targeted intervention strategies to mitigate limb loss in this vulnerable cohort.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rokosh RS, Sperling L, Quyyumi A, et al. Premature peripheral arterial disease is associated with worse outcomes after endovascular peripheral vascular intervention. J Vasc Surg. 2026. PMID: 42398680. doi:10.1016/j.jvs.2026.06.154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。